InvestorsHub Logo
Followers 29
Posts 2217
Boards Moderated 0
Alias Born 12/13/2016

Re: kevindenver post# 134217

Wednesday, 12/13/2017 5:12:03 PM

Wednesday, December 13, 2017 5:12:03 PM

Post# of 466029
Kevin, thought the same thing when I read about cooperative trials with multi companies involved. I guess ACTC will have to rule with a strong hand and the FDA/NIH will have the other hand on the "purse strings". Both Gottlieb and Woodcock are intelligent and strong leaders and will push for real progress in Alzheimer's treatment.

The other question will be how companies like Biogen who have sunk a ton one money and time into drugs like Aducanumab will react to the new precision medical trials being offered to young upstart competitors. As I said before, no other company could have so great a positive or negative impact on Biogen than can Anavex. IMHO Michel Vounatsos still is maintaining a close eye on us.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News